<div class="headers"><div>Fig. 2. Responses at baseline and endpoint to insulin glargine and insulin lispro mix 25 by baseline HbA1c quartiles: (a) fasting hyperglycaemia (FHG) area under the curve (AUC); and (b) postprandial hyperglycaemia (PHG) AUC</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<tbody>
<tr style='border-top: 2px solid grey;'>
<td style='border-top: 2px solid grey; border-bottom: 2px solid grey; text-align: left;'><p class="">Fig. 2. Responses at baseline and endpoint to insulin glargine and insulin lispro mix 25 by baseline HbA1c quartiles: (a) fasting hyperglycaemia (FHG) area under the curve (AUC); and (b) postprandial hyperglycaemia (PHG) AUC</p></td>
</tr>
</tbody>
</table>
